Table 1.
Characteristics | N = 22, n (%) |
---|---|
Gender | |
Male | 13 (59%) |
Female | 9 (41%) |
Age, years, median (range) | 60 (41–82) |
Race | |
White | 19 (86%) |
African American | 1 (5%) |
Missing | 2 (9%) |
ECOG | |
0 | 4 (18%) |
1 | 18 (82%) |
Prior therapy | |
Surgery | 14 (64%) |
Radiotherapy | 20 (91%) |
Prior systemic treatments | |
0 | 6 (27%) |
1 | 7 (32%) |
≥ 2 | 9 (41%) |
Metastatic Disease | 22 (100%) |
Sites of metastases | |
Lung | 20 (91%) |
Bone | 8 (36%) |
Liver | 5 (23%) |
Lymph node | 5 (23%) |
Notch ICD IHC | |
Positive | 14 (64%) |
Negative | 8 (36%) |
ECOG, Eastern Cooperative Oncology Group; NICD, Notch-1 intracellular domain